Skip to content

Clinical trials

Phase 3 Muscular Dystrophy, Duchenne trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Phase: Phase 3 Country / region: United States Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20101
20134
20142
20151
20162
20172
20183
20191
20204
20212
20221
20233
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated12
Active, not recruiting4
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sarepta Therapeutics, Inc.7
PTC Therapeutics4
Santhera Pharmaceuticals3
Catabasis Pharmaceuticals2
Cooperative International Neuromuscular Research Group2
Kyntra Bio2
Pfizer2
BioMarin Pharmaceutical1
Capricor Inc.1
Dyne Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne32
Muscular Dystrophies13
Neuromuscular Diseases9
Genetic Diseases, Inborn6
Genetic Diseases, X-Linked6
Musculoskeletal Diseases6
Muscular Diseases5
Muscular Disorders, Atrophic5
Nervous System Diseases5
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.